Page 1 | Search Results | Blood | American Society of Hematology

1-18 of 18

Sort by

Sort Order Select

Journal Articles

Prognostic Factors for Survival after Allogeneic Transplantation in Acute Lymphoblastic Leukemia

Christine Greil, Monika Engelhardt, MD, Gabriele Ihorst, Hartmut Bertz, MD, Reinhard Marks, MD, Robert Zeiser, MD, Justus Duyster, MD, Jürgen Finke, MD, Ralph Wäsch, MD

Blood (2019) 134 (Supplement_1): 4597.

https://doi.org/10.1182/blood-2019-130146

Published: 2019

Journal Articles

Thiotepa-Fludarabine-Treosulfan (TFT) Conditioning for 2nd Allogeneic Peripheral Blood Hematopoietic Cell Transplantation (HCT) from a Second Unrelated Donor in Patients with Acute Myeloid Leukemia (AML) Relapsed after Prior Allogeneic HCT: A Prospective Multicenter Phase II Trial

Jürgen Finke, MD, Claudia Schmoor, Matthias Stelljes, MD, Andreas Burchert, MD, Peter Dreger, Eva-Maria Wagner, MD, Martin Bornhäuser, Kristina Sohlbach, MD, Natalie Schub, MD, Christian Reicherts, Guido Kobbe, Bertram Glass, Hartmut Bertz, MD, Olga Grishina

Blood (2018) 132 (Supplement 1): 210.

https://doi.org/10.1182/blood-2018-99-118999

Published: 2018

Journal Articles

Metabolic Reprogramming Overcomes T Cell Inhibition By AML Cells

Franziska Maria Uhl, MSc, Sophia Chen, MD, David O'Sullivan, PhD, Michael Buck, PhD, Jörg Büscher, PhD, Dietmar Pfeifer, Jürgen Finke, MD, Justus Duyster, Prof., Hartmut Bertz, MD, Khalid Shoumariyeh, MD, Melanie Börries, PhD, Gesa Richter, MSc, Tobias Madl, PhD, Erika L. Pearce, PhD, Robert Zeiser, MD

Blood (2018) 132 (Supplement 1): 3328.

https://doi.org/10.1182/blood-2018-99-112897

Published: 2018

Journal Articles

Decitabine (DAC) in Combination with Donor Lymphocyte Infusions (DLIs) Can Induce Remissions of Overt Aml Relapses after Allogeneic Transplantation

Sebastian Sommer, MD, Rainer Claus, MD, Hartmut Bertz, MD, Ralph Wäsch, MD, Reinhard Marks, MD, Robert Zeiser, MD, Ljudmila Bogatyrova, Jürgen Finke, MD, Michael Lübbert, MD

Blood (2016) 128 (22): 2247.

https://doi.org/10.1182/blood.V128.22.2247.2247

Published: 2016

Journal Articles

Long-Term Follow-up of Patients with Corticosteroid-Refractory Graft-Versus-Host Disease Treated with Ruxolitinib

Robert Zeiser, MD, Andreas Burchert, MD, Claudia Lengerke, MD, Mareike Verbeek, Kristina Maas-Bauer, MD, Stephan Metzelder, MD, Silvia Spoerl, MD, Markus Ditschkowski, MD, Matyas Ecsedi, MD, Katja Sockel, MD, Francis Ayuk, MD, Ajib Salem, MD, Flore Sicre de Fontbrune, MD, Il-Kang Na, MD, Penter Livius, MD, Udo Holtick, MD PhD, Dominik Wolf, MD, Esther Schuler, MD, Everett Meyer, MD PhD, Petya Apostolova, MD, Hartmut Bertz, MD, Reinhard Marks, MD, Michael Lübbert, MD, Ralph Wäsch, MD, Christof Scheid, MD PhD, Friedrich Stölzel, MD, Rainer Ordemann, MD, Gesine Bug, MD, Guido Kobbe, MD, Omid Shah, MD, Robert S. Negrin, MD, Mats Brune, MD PhD, Alexandros Spyridonidis, MD PhD, Annette Schmitt-Graeff, MD, Walter J.F.M. van der Velden, MD PhD, Gerwin Huls, MD PhD, Stephan Mielke, MD, Goetz Ulrich Grigoleit, MD, Jurgen Kuball, MD PhD, Ryan P Flynn, PhD, Gabriele Ihorst, PhD, Jing Du, Bruce R. Blazar, MD, Renate Arnold, MD, Nicolaus Kröger, MD, Jakob R. Passweg, Joerg Halter, MD, Gérard Socié, MD PhD, Dietrich W. Beelen, Prof. Dr. MD, Christian Peschel, MD, Andreas Neubauer, Jürgen Finke, Justus Duyster, MD, Nikolas von Bubnoff, MD

Blood (2016) 128 (22): 4561.

https://doi.org/10.1182/blood.V128.22.4561.4561

Published: 2016

Journal Articles

Impact of Donor-Recipient Histocompatibility and CMV-Mismatch on Outcome of Allogeneic Stem Cell Transplantation for AML and MDS: A Retrospective Registry Study of the German Stem Cell Transplant Registry (DRST) of the German Working Group for Blood and Marrow Transplantation (DAG-KBT)

Francis A. Ayuk, MD, Dietrich W. Beelen, Prof. Dr. MD, Martin Bornhäuser, MD, Matthias Stelljes, Tajana Zabelina, MD, Jürgen Finke, Guido Kobbe, MD, Daniel Wolff, MD, Eva Maria Wagner, MD, Maximilian Christopeit, MD, Christoph Schmid, MD, Hellmut Ottinger, MD, Christoph Groth, MD, Christoph Faul, MD, Hartmut Bertz, MD, Elena Rachlis, MD, Christine Wolschke, MD, Nicolaus Kröger, MD, Wolfgang Bethge, MD

Blood (2016) 128 (22): 2304.

https://doi.org/10.1182/blood.V128.22.2304.2304

Published: 2016

Journal Articles

Aspergillus Specific PCR and Galactomannan of Bronchoalveolar Lavage Are Superior to Concomitant Same-Day Testing of Concurrent Blood Samples in Immunocompromised Hematological Patients with Suspected Invasive Aspergillosis

Tobias Boch, MD, Birgit Spiess, PhD, Oliver Cornely, MD, Werner J. Heinz, MD, Joachim Hahn, MD, Stefan W. Krause, MD, Hartmut Bertz, MD, Wolf-Karsten Hofmann, MD, Dieter Buchheidt, MD, Mark Reinwald, MD

Blood (2015) 126 (23): 2072.

https://doi.org/10.1182/blood.V126.23.2072.2072

Published: 2015

Journal Articles

Randomized Trial on GvHD Prophylaxis with or without Anti-Human T-Lymphocyte Immunoglobulin ATG-Fresenius (ATG-F) in Allogeneic Hematopoietic Cell Transplantation from Matched Unrelated Donors: Final Long-Term Results after 8.6 Years Median Follow-up

Jürgen Finke, MD, Claudia Schmoor, PhD, Wolfgang A Bethge, MD, Hellmut Ottinger, Priv.-Doz. Dr. MD, Matthias Stelljes, Liisa Volin, MD PhD, Dominik Heim, MD, Hartmut Bertz, MD, Olga Grishina, MD, Gerard Socie

Blood (2015) 126 (23): 853.

https://doi.org/10.1182/blood.V126.23.853.853

Published: 2015

Journal Articles

Treatment of Corticosteroid-Refractory Graft-Versus-Host Disease with Ruxolitinib in 95 Patients

Robert Zeiser, MD, Andreas Burchert, MD, Claudia Lengerke, MD, Mareike Verbeek, Kristina Maas-Bauer, MD, Stephan Metzelder, MD, Silvia Spoerl, MD, Markus Ditschkowski, MD, Matyas Ecsedi, MD, Katja Sockel, MD, Francis Ayuk, MD, Salem Ajib, MD, Flore Sicre de Fontbrune, MD, Il-Kang Na, MD, Livius Penter, MD, Udo Holtick, MD PhD, Dominik Wolf, MD, Esther Schuler, MD, Everett Meyer, MD PhD, Petya Apostolova, MD, Hartmut Bertz, MD, Reinhard Marks, Michael Luebbert, MD, Ralph M. Waesch, MD PhD, Christof Scheid, MD PhD, Friedrich Stölzel, MD, Rainer Ordemann, MD, Gesine Bug, MD, Guido Kobbe, MD, Robert Negrin, MD, Mats L Brune, Alexandros Spyridonidis, Annette Schmitt-Graeff, MD, Walter van der Velden, MD, Gerwin Huls, MD PhD, Stephan Mielke, MD, Goetz Ulrich Grigoleit, MD, Jurgen Kuball, MDPhD, Ryan P Flynn, PhD, Gabriele Ihorst, PhD, Jing Du, Bruce R. Blazar, MD, Renate Arnold, MD, Nicolaus Kröger, MD, Joerg Halter, MD, Gerard Socie, Dietrich Beelen, MD, Christian Peschel, MD, Andreas Neubauer, MD, Juergen Finke, MD, Justus Duyster, MD PhD, Nikolas von Bubnoff, MD

Blood (2015) 126 (23): 858.

https://doi.org/10.1182/blood.V126.23.858.858

Published: 2015

Journal Articles

Investigation Of Fresh Tissue and Effusion Samples From Immunocompromised Hematologic Patients Suspected For Invasive Fungal Infection With An Aspergillus- specific PCR Is a Promising Tool For Identifying Invasive Aspergillosis

Blood (2013) 122 (21): 4552.

https://doi.org/10.1182/blood.V122.21.4552.4552

Published: 2013

Journal Articles

Low-Dose 5-Azacytidine Combined With Donor Lymphocyte Infusions (DLI), An Effective Outpatient Treatment Of AML/MDS Relapse After Allografting, Can Induce Long-Term Remissions: An Experience Of 72 Patients

Juliane Katharina Steinmann, Hartmut Bertz, MD, Ralph Wäsch, MD, Reinhard Marks, MD, Robert Zeiser, Lioudmila Bogatyreva, Michael Lübbert, MD, PhD, Jürgen Finke, MD

Blood (2013) 122 (21): 3317.

https://doi.org/10.1182/blood.V122.21.3317.3317

Published: 2013

Journal Articles

Allogeneic Stem Cell Transplantation - A Long-Term Curative Approach In Patients ≥ 60 Years With Advanced Disease AML/MDS, - The Freiburg Experience Of 250 Consecutive Patients

Hartmut Bertz, MD, Michael Lübbert, MD, Kristin Ohneberg, Ralph Wäsch, MD, Robert Zeiser, Reinhard Marks, Jürgen Finke, MD

Blood (2013) 122 (21): 2135.

https://doi.org/10.1182/blood.V122.21.2135.2135

Published: 2013

Journal Articles

Analysis of Efficacy and Costs of Antifungal Prophylaxis in Patients Undergoing Chemotherapy for Acute Leukemia: “Real Life” Evaluation

Hartmut Bertz, MD, Kathrin Drognitz, MD, Tatjana Proskurin, Michael Lubbert

Blood (2011) 118 (21): 2081.

https://doi.org/10.1182/blood.V118.21.2081.2081

Published: 2011

Journal Articles

Therapeutic Granulocyte Transfusions in Neutropenic Patients with Invasive Pulmonary Aspergillosis,

Kathrin Drognitz, MD, Michael Lubbert, Gerald Illerhaus, Frank Gartner, Hartmut Bertz, MD

Blood (2011) 118 (21): 3372.

https://doi.org/10.1182/blood.V118.21.3372.3372

Published: 2011

Journal Articles

Analysis of Efficacy, Safety and Costs of Systemic Antifungal Agents in 159 Consecutive High-Risk Cancer Patients for the Establishment of Standardized Guidelines

Werner Neubauer, Martina Kleber, MD, Alf Zerweck, MD, Veronique Thierry, MD, Alexandra Goebel, PhD, Beate Lubrich, PhD, Hartmut Bertz, MD, Monika Engelhardt, MD

Blood (2008) 112 (11): 1313.

https://doi.org/10.1182/blood.V112.11.1313.1313

Published: 2008

Journal Articles

Conditioning with Fludarabine, BCNU, and Melphalan in Allogeneic Stem Cell Transplantation Results in Reduced Toxixcity and High Activity Against Advanced Hematologic Malignancies.

Reinhard Marks, MD, Karin Potthoff, MD, Joachim Hahn, MD, Gabriele Ihorst, Hartmut Bertz, MD, Alexandros Spyridonidis, MD, Ernst Holler, MD, Jurgen Finke, MD

Blood (2007) 110 (11): 3066.

https://doi.org/10.1182/blood.V110.11.3066.3066

Published: 2007

Journal Articles

Non-Intensive AML/MDS Treatment with Low-Dose Decitabine Prior to Reduced-Intensity Conditioning (RIC) and Allogeneic Blood Stem Cell Transplantation of Older Patients.

Michael Lübbert, MD, PhD, Hartmut Bertz, MD, PhD, Björn H. Rüter, MD, Roland H. Mertelsmann, MD, PhD, Jürgen Finke, MD, PhD

Blood (2006) 108 (11): 5257.

https://doi.org/10.1182/blood.V108.11.5257.5257

Published: 2006

Journal Articles

Frequent Genomic Alterations in Epithelium Measured by Microsatellite Instability Following Allogeneic Hematopoietic Cell Transplantation in Humans.

Alexandros Spyridonidis, MD, Philipp Faber, Paul Fisch, MD, Miguel Waterhouse, Annette Schmitt-Graeff, MD, Hartmut Bertz, MD, Juergen Finke, MD

Blood (2005) 106 (11): 1117.

https://doi.org/10.1182/blood.V106.11.1117.1117

Published: 2005

NARROW

Prognostic Factors for Survival after Allogeneic Transplantation in Acute Lymphoblastic Leukemia

Thiotepa-Fludarabine-Treosulfan (TFT) Conditioning for 2nd Allogeneic Peripheral Blood Hematopoietic Cell Transplantation (HCT) from a Second Unrelated Donor in Patients with Acute Myeloid Leukemia (AML) Relapsed after Prior Allogeneic HCT: A Prospective Multicenter Phase II Trial

Metabolic Reprogramming Overcomes T Cell Inhibition By AML Cells

Decitabine (DAC) in Combination with Donor Lymphocyte Infusions (DLIs) Can Induce Remissions of Overt Aml Relapses after Allogeneic Transplantation

Long-Term Follow-up of Patients with Corticosteroid-Refractory Graft-Versus-Host Disease Treated with Ruxolitinib

Impact of Donor-Recipient Histocompatibility and CMV-Mismatch on Outcome of Allogeneic Stem Cell Transplantation for AML and MDS: A Retrospective Registry Study of the German Stem Cell Transplant Registry (DRST) of the German Working Group for Blood and Marrow Transplantation (DAG-KBT)

Aspergillus Specific PCR and Galactomannan of Bronchoalveolar Lavage Are Superior to Concomitant Same-Day Testing of Concurrent Blood Samples in Immunocompromised Hematological Patients with Suspected Invasive Aspergillosis

Randomized Trial on GvHD Prophylaxis with or without Anti-Human T-Lymphocyte Immunoglobulin ATG-Fresenius (ATG-F) in Allogeneic Hematopoietic Cell Transplantation from Matched Unrelated Donors: Final Long-Term Results after 8.6 Years Median Follow-up

Treatment of Corticosteroid-Refractory Graft-Versus-Host Disease with Ruxolitinib in 95 Patients

Investigation Of Fresh Tissue and Effusion Samples From Immunocompromised Hematologic Patients Suspected For Invasive Fungal Infection With An Aspergillus- specific PCR Is a Promising Tool For Identifying Invasive Aspergillosis

Low-Dose 5-Azacytidine Combined With Donor Lymphocyte Infusions (DLI), An Effective Outpatient Treatment Of AML/MDS Relapse After Allografting, Can Induce Long-Term Remissions: An Experience Of 72 Patients

Allogeneic Stem Cell Transplantation - A Long-Term Curative Approach In Patients ≥ 60 Years With Advanced Disease AML/MDS, - The Freiburg Experience Of 250 Consecutive Patients

Analysis of Efficacy and Costs of Antifungal Prophylaxis in Patients Undergoing Chemotherapy for Acute Leukemia: “Real Life” Evaluation

Therapeutic Granulocyte Transfusions in Neutropenic Patients with Invasive Pulmonary Aspergillosis,

Analysis of Efficacy, Safety and Costs of Systemic Antifungal Agents in 159 Consecutive High-Risk Cancer Patients for the Establishment of Standardized Guidelines

Conditioning with Fludarabine, BCNU, and Melphalan in Allogeneic Stem Cell Transplantation Results in Reduced Toxixcity and High Activity Against Advanced Hematologic Malignancies.

Non-Intensive AML/MDS Treatment with Low-Dose Decitabine Prior to Reduced-Intensity Conditioning (RIC) and Allogeneic Blood Stem Cell Transplantation of Older Patients.

Frequent Genomic Alterations in Epithelium Measured by Microsatellite Instability Following Allogeneic Hematopoietic Cell Transplantation in Humans.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only